Deep-learning-assisted biophysical imaging cytometry at massive throughput delineates cell population heterogeneity. Issue 20 (16th September 2020)

• Record Type: Journal Article
• Authors: Siu, Dickson M. D.; Lee, Kelvin C. M.; Lo, Michelle C. K.; Stassen, Shobana V.; Wang, Maolin; Zhang, Iris Z. Q.; So, Hayden K. H.; Chan, Godfrey C. F.; Cheah, Kathryn S. E.; Wong, Kenneth K. Y.; Hsin, Michael K. Y.; Ho, James C. M.; Tsia, Kevin K.
• Is Part Of: Lab on a chip. Volume 20:Issue 20(2020)
• Page Start: 3696
• Page End: 3708
• Publication Date: 2020-09-16
• Subjects: Miniature electronic equipment -- Periodicals; Combinatorial chemistry -- Periodicals; Biotechnology -- Periodicals; 543.0813
• DOI: 10.1039/d0lc00542h
• Languages: English
• ISSNs: 1473-0197

Abstract

Abstract : An optofluidic imaging cytometry strategy that hierarchically analyzes single-cell biophysical morphology beyond millions of cells at high sensitivity and specificity. Abstract : The association of the intrinsic optical and biophysical properties of cells to homeostasis and pathogenesis has long been acknowledged. Defining these label-free cellular features obviates the need for costly and time-consuming labelling protocols that perturb the living cells. However, wide-ranging applicability of such label-free cell-based assays requires sufficient throughput, statistical power and sensitivity that are unattainable with current technologies. To close this gap, we present a large-scale, integrative imaging flow cytometry platform and strategy that allows hierarchical analysis of intrinsic morphological descriptors of single-cell optical and mass density within a population of millions of cells. The optofluidic cytometry system also enables the synchronous single-cell acquisition of and correlation with fluorescently labeled biochemical markers. Combined with deep neural network and transfer learning, this massive single-cell profiling strategy demonstrates the label-free power to delineate the biophysical signatures of the cancer subtypes, to detect rare populations of cells in the heterogeneous samples (10–5), and to assess the efficacy of targeted therapeutics. This technique could spearhead the development of optofluidic imaging cell-based assays that stratify the underlying physiological and pathological processes based on the information-rich biophysical cellular phenotypes.